Pacific Edge

Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The company is currently developing and commercialising its range of Cxbladder bladder cancer tests globally through its wholly owned central laboratories in New Zealand and the USA. As it stands Pacific Edge has four proprietary, novel, accurate, molecular diagnostic products in-market providing actionable results for the better detection and management of urothelial cancer. These products have been extensively tested and validated in international multi-center clinical studies.


Company Details

Registered Office: Anderson Lloyd, Level 10, Otago House, Cnr Moray Place And Princes Street, Dunedin 9016
Postal Address: PO Box 56, Dunedin 9016
Telephone: +64-3-479-5800
Facsimile: n/a
Website: http://www.pacificedgedx.com
First Listed: 01/10/2003
Balance Date: 31 March
AGM: 27/07/2023

Directors and Executives

Tony Barclay
Independent Director
Chris Gallaher
Chairman
Grant Gibson
Chief Financial Officer
Mark Green
Independent Director
Anatole Masfen
Independent Director
Peter Meintjes
Chief Executive Officer
Sarah Park
Independent Director
Anna Stove
Independent Director
Bryan Williams
Independent Director

Major Holdings Announcements

Date Name No. Held % Current
17/04/23 ANZ New Zealand Investments Limited 58,714,600 6.18 7.25
18/01/23 Harbour Asset Management Limited an 127,988,137 14.78 15.79
10/12/21 Salt Funds Management Limited 48,114,089 6.95 5.94
30/09/21 Westpac Banking Corporation 52,810,384 8.14 6.70
03/12/20 AMP Capital Investors (New Zealand) 36,125,581 5.16 4.98
03/12/18 Jarden Partners Limited. 83,613,923 15.60 17.61
06/06/18 BNP Paribas Nominees (NZ) Limited a 20,612,121 5.47 4.42
05/07/17 Investment Services Group Limited 19,015,596 5.94 4.76
05/07/17 Devon Funds Management Limited 19,015,596 5.94 4.76
28/06/17 Harbour Asset Management & Jarden P 48,540,480 11.11 12.14
17/02/17 K One W One Limited 19,786,297 5.39 4.96
07/11/16 Superlife Trustee Nominees Limited, 2,033,501 5.99 0.53

Director’s Interests Announcements

Date Name No. Held % Details Other
21/12/22 Peter Meintjes 185,000 - - -
22/03/22 Antony George Barclay 20,000 - - -
09/12/21 Bryan Williams 237,427 - - -
22/10/21 David Gregory Darling 4,611,562 - - -
22/10/21 Grant Edward Gibson 27,456 - - -
20/10/21 Sarah Park 58,591 - - -
06/10/21 Chris Gallaher 602,058 - - -
16/03/21 Anna Kate Stove 5,000 - - -
19/12/19 Kate Elizabeth Rankin 1,775,890 - - -
16/08/19 James Miller Suttie 190,568 - - -
30/05/19 John Duncan 900,333 - - -
30/06/16 Christopher John Swann 1,171,641 0.37 - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 08/06/2023


Markets News

NZ stocks end flat amid Fletcher-SkyCity legal woes
Markets Market Close

NZ stocks end flat amid Fletcher-SkyCity legal woes

Tesla's 14% drop again highlighted the general state of global market uncertainty.

Jamie Gray 06 Jun 2025
Markets

SkyCity claims it is entitled to $330m in damages from Fletcher Building

The original delivery date of the International Convention Centre was January 2019. 

Rebecca Howard 06 Jun 2025
SkyCity claims it is entitled to $330m in damages from Fletcher Building
Markets

10 NZ firms could get slice of $200m Fisher KiwiSaver cash

Private equity investing will benefit both KiwiSavers and business, fund manager says.

10 NZ firms could get slice of $200m Fisher KiwiSaver cash
Markets Small Cap Wrap

The firm bearing the brunt of public sector cutbacks

Plus Being AI, takeover madness, and more.

The firm bearing the brunt of public sector cutbacks
Markets Market Close

Property companies help boost NZ sharemarket

Ryman Healthcare, Argosy Property and Goodman all saw share-price rises.

Tom Raynel 05 Jun 2025
Property companies help boost NZ sharemarket